Honey Health

Honey Health, based in the US, delivers an innovative AI-driven back office solution tailored for the healthcare sector, enhancing operational efficiency by automating administrative tasks. Honey Health provides AI solutions for healthcare administration, founded in 2024 in the US. The company completed its only funding round on October 27, 2025, raising USD 7. 8 mn in Seed funding led by Pelion Venture Partners, with participation from 8-Bit Capital, Burst Capital, and Streamlined Ventures.

Honey Health offers a comprehensive AI-driven back office solution designed specifically for the healthcare sector, integrating seamlessly into existing Electronic Health Record (EHR) systems. Their core offerings include an AI workforce capable of automating various administrative tasks such as data fetching and interoperability, note preparation and pre-charting, processing orders and refills, and managing fax triage and prior authorizations. This suite of services aims to alleviate the administrative burden on healthcare professionals, allowing them to focus more on patient care. Honey Health primarily serves group practices, hospitals, health systems, management services organizations (MSOs), and other healthcare entities.

The company targets markets in the United States and has begun expanding its presence in segments that include cardiology, orthopedics, and other specialties, positioning itself as a tailored solution for diverse healthcare needs. Honey Health employs a subscription-based revenue model, allowing healthcare organizations to access its AI-driven services tailored to their specific needs. Clients typically engage in contracts that provide them with a dedicated AI team designed for their unique workflows, ensuring that the technology is closely aligned with their operational demands. Revenue is generated through these subscription agreements, which encompass the deployment of Honey's range of services, including automation tools for prior authorizations and patient data management.

The structure of these transactions emphasizes long-term partnerships, enabling clients to scale their use of Honey's services as their operational needs evolve. In October 2025, Honey Health raised USD 7. 8 mn in Seed funding led by Pelion Venture Partners, which will be utilized to advance its artificial intelligence systems for automating administrative tasks and to continue supporting healthcare clients. The company aims to launch new features in its AI offerings and plans to expand its market presence within the healthcare sectors of cardiology and orthopedics by mid-2026.